TRC 4186

Drug Profile

TRC 4186

Alternative Names: TRC-4186; TX-41XX

Latest Information Update: 13 Aug 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Torrent Pharmaceuticals
  • Class Small molecules
  • Mechanism of Action Advanced glycosylation end product inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • No development reported Diabetic complications; Heart failure

Most Recent Events

  • 13 Aug 2015 No recent reports on development identified - Phase-II for Diabetic complications/Heart failure associated with hyperglycaemia/diabetes (Adjunctive treatment) in India, Netherlands, Russia, Serbia, United Kingdom (PO)
  • 11 Apr 2012 Torrent Pharmaceuticals completes a phase II trial in India, the Netherlands, Russia, Serbia, and the United Kingdom
  • 10 Dec 2009 Phase-II clinical trials in Diabetic complications in Netherlands (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top